HEADER TRANSFERASE 23-JUL-15 5CSW TITLE B-RAF IN COMPLEX WITH DABRAFENIB COMPND MOL_ID: 1; COMPND 2 MOLECULE: SERINE/THREONINE-PROTEIN KINASE B-RAF; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: KINASE DOMAIN, UNP RESIDUES 442-721; COMPND 5 SYNONYM: PROTO-ONCOGENE B-RAF,P94,V-RAF MURINE SARCOMA VIRAL ONCOGENE COMPND 6 HOMOLOG B1; COMPND 7 EC: 2.7.11.1; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BRAF, BRAF1, RAFB1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS KINASE, PROTEROS BIOSTRUCTURES GMBH, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR G.BADER,H.STADTMULLER,S.STEURER REVDAT 4 10-JAN-24 5CSW 1 REMARK REVDAT 3 25-APR-18 5CSW 1 TITLE REMARK REVDAT 2 16-MAR-16 5CSW 1 JRNL REVDAT 1 09-MAR-16 5CSW 0 JRNL AUTH I.C.WAIZENEGGER,A.BAUM,S.STEURER,H.STADTMULLER,G.BADER, JRNL AUTH 2 O.SCHAAF,P.GARIN-CHESA,A.SCHLATTL,N.SCHWEIFER,C.HASLINGER, JRNL AUTH 3 F.COLBATZKY,S.MOUSA,A.KALKUHL,N.KRAUT,G.R.ADOLF JRNL TITL A NOVEL RAF KINASE INHIBITOR WITH DFG-OUT-BINDING MODE: HIGH JRNL TITL 2 EFFICACY IN BRAF-MUTANT TUMOR XENOGRAFT MODELS IN THE JRNL TITL 3 ABSENCE OF NORMAL TISSUE HYPERPROLIFERATION. JRNL REF MOL.CANCER THER. V. 15 354 2016 JRNL REFN ESSN 1538-8514 JRNL PMID 26916115 JRNL DOI 10.1158/1535-7163.MCT-15-0617 REMARK 2 REMARK 2 RESOLUTION. 2.66 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0109 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.66 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 100.73 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 15159 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.220 REMARK 3 R VALUE (WORKING SET) : 0.217 REMARK 3 FREE R VALUE : 0.282 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.300 REMARK 3 FREE R VALUE TEST SET COUNT : 849 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.66 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.73 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1074 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.22 REMARK 3 BIN R VALUE (WORKING SET) : 0.2780 REMARK 3 BIN FREE R VALUE SET COUNT : 74 REMARK 3 BIN FREE R VALUE : 0.3590 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4059 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 71 REMARK 3 SOLVENT ATOMS : 16 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 24.93 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 5.65000 REMARK 3 B22 (A**2) : -4.14000 REMARK 3 B33 (A**2) : -1.72000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -1.13000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.392 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.323 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 31.132 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.926 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.895 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4069 ; 0.012 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 2791 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5506 ; 1.308 ; 1.974 REMARK 3 BOND ANGLES OTHERS (DEGREES): 6710 ; 1.020 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 501 ; 6.612 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 166 ;37.216 ;23.434 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 673 ;15.231 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 26 ;11.273 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 606 ; 0.072 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4487 ; 0.005 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 823 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2517 ; 1.556 ; 2.000 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1022 ; 0.350 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4025 ; 2.731 ; 3.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1552 ; 4.298 ; 4.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1481 ; 6.246 ; 6.000 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS U VALUES : RESIDUAL ONLY REMARK 4 REMARK 4 5CSW COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 23-JUL-15. REMARK 100 THE DEPOSITION ID IS D_1000212125. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-JUL-10 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X06SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9996 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 16044 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.660 REMARK 200 RESOLUTION RANGE LOW (A) : 100.730 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 4.100 REMARK 200 R MERGE (I) : 0.09000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 4.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.66 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.87 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.8 REMARK 200 DATA REDUNDANCY IN SHELL : 4.00 REMARK 200 R MERGE FOR SHELL (I) : 0.43800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 3C4C REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.49 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.25 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 3350, VAPOR DIFFUSION, HANGING REMARK 280 DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 57.17950 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 24.04750 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 57.17950 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 24.04750 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 442 REMARK 465 PRO A 443 REMARK 465 ARG A 444 REMARK 465 ASP A 445 REMARK 465 SER A 446 REMARK 465 SER A 447 REMARK 465 ASP A 448 REMARK 465 GLY A 596 REMARK 465 LEU A 597 REMARK 465 ALA A 598 REMARK 465 THR A 599 REMARK 465 VAL A 600 REMARK 465 LYS A 601 REMARK 465 SER A 602 REMARK 465 ARG A 603 REMARK 465 TRP A 604 REMARK 465 SER A 605 REMARK 465 GLY A 606 REMARK 465 SER A 607 REMARK 465 HIS A 608 REMARK 465 GLN A 609 REMARK 465 PHE A 610 REMARK 465 GLU A 611 REMARK 465 GLN A 612 REMARK 465 LEU A 613 REMARK 465 SER A 614 REMARK 465 SER A 722 REMARK 465 GLY A 723 REMARK 465 GLY B 442 REMARK 465 PRO B 443 REMARK 465 ARG B 444 REMARK 465 ASP B 445 REMARK 465 SER B 446 REMARK 465 ALA B 598 REMARK 465 THR B 599 REMARK 465 VAL B 600 REMARK 465 LYS B 601 REMARK 465 SER B 602 REMARK 465 ARG B 603 REMARK 465 TRP B 604 REMARK 465 SER B 605 REMARK 465 GLY B 606 REMARK 465 SER B 607 REMARK 465 HIS B 608 REMARK 465 GLN B 609 REMARK 465 PHE B 610 REMARK 465 GLU B 611 REMARK 465 GLN B 612 REMARK 465 LEU B 613 REMARK 465 SER B 614 REMARK 465 GLY B 615 REMARK 465 MET B 627 REMARK 465 GLN B 628 REMARK 465 ASP B 629 REMARK 465 SER B 630 REMARK 465 ASN B 631 REMARK 465 SER B 722 REMARK 465 GLY B 723 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 ASP A 454 CG OD1 OD2 REMARK 480 LYS A 473 NZ REMARK 480 THR A 488 OG1 CG2 REMARK 480 GLN A 493 CG CD OE1 NE2 REMARK 480 GLU A 501 CG CD OE1 OE2 REMARK 480 LYS A 507 CG CD CE NZ REMARK 480 LYS A 522 CG CD CE NZ REMARK 480 LYS A 547 CG CD CE NZ REMARK 480 LYS A 551 NZ REMARK 480 LYS A 552 NZ REMARK 480 ASN A 588 OD1 ND2 REMARK 480 GLU A 667 CG CD OE1 OE2 REMARK 480 ARG A 671 CG CD NE CZ NH1 NH2 REMARK 480 LYS A 690 CG CD CE NZ REMARK 480 LYS A 698 CE NZ REMARK 480 LYS A 700 CG CD CE NZ REMARK 480 ARG A 709 CG CD NE CZ NH1 NH2 REMARK 480 ARG A 719 CG CD NE CZ NH1 NH2 REMARK 480 GLU A 720 CD OE1 OE2 REMARK 480 ASP B 448 CG OD1 OD2 REMARK 480 ASP B 449 CG OD1 OD2 REMARK 480 ASP B 454 CG OD1 OD2 REMARK 480 GLN B 461 CG CD OE1 NE2 REMARK 480 PHE B 468 CG CD1 CD2 CE1 CE2 CZ REMARK 480 LYS B 473 NZ REMARK 480 THR B 488 OG1 CG2 REMARK 480 GLN B 493 CG CD OE1 NE2 REMARK 480 LEU B 495 CG CD1 CD2 REMARK 480 LYS B 499 CE NZ REMARK 480 GLU B 501 CG CD OE1 OE2 REMARK 480 LYS B 507 CG CD CE NZ REMARK 480 LYS B 522 CG CD CE NZ REMARK 480 GLU B 533 CG CD OE1 OE2 REMARK 480 LYS B 547 CG CD CE NZ REMARK 480 LYS B 551 NZ REMARK 480 LYS B 552 NZ REMARK 480 ASN B 588 OD1 ND2 REMARK 480 ASN B 661 CG OD1 ND2 REMARK 480 GLU B 667 CG CD OE1 OE2 REMARK 480 ARG B 671 CD NE CZ NH1 NH2 REMARK 480 LYS B 680 CG CD CE NZ REMARK 480 LYS B 690 CG CD CE NZ REMARK 480 LYS B 700 CG CD CE NZ REMARK 480 ARG B 709 CG CD NE CZ NH1 NH2 REMARK 480 ARG B 719 CG CD NE CZ NH1 NH2 REMARK 480 GLU B 720 CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TRP A 476 103.14 -163.18 REMARK 500 ALA A 489 65.81 63.87 REMARK 500 ALA A 543 -62.36 -138.24 REMARK 500 ARG A 575 -16.54 86.25 REMARK 500 ASP A 576 44.22 -146.33 REMARK 500 ASN A 588 -44.01 -141.90 REMARK 500 SER A 616 46.88 -158.22 REMARK 500 ASN A 631 79.66 -111.57 REMARK 500 LEU A 674 111.56 -164.43 REMARK 500 ARG A 701 -64.60 -10.62 REMARK 500 ALA B 489 72.03 65.75 REMARK 500 PRO B 492 -37.56 -38.96 REMARK 500 THR B 521 -54.15 -121.11 REMARK 500 ARG B 575 -11.78 80.79 REMARK 500 ASP B 576 48.37 -155.96 REMARK 500 LYS B 578 151.19 178.18 REMARK 500 GLU B 586 19.98 57.96 REMARK 500 ASN B 588 -55.40 -154.22 REMARK 500 LEU B 674 114.35 -163.69 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue P06 A 801 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue P06 B 801 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL B 802 DBREF 5CSW A 442 721 UNP P15056 BRAF_HUMAN 442 721 DBREF 5CSW B 442 721 UNP P15056 BRAF_HUMAN 442 721 SEQADV 5CSW PRO A 443 UNP P15056 ARG 443 ENGINEERED MUTATION SEQADV 5CSW ALA A 543 UNP P15056 ILE 543 ENGINEERED MUTATION SEQADV 5CSW SER A 544 UNP P15056 ILE 544 ENGINEERED MUTATION SEQADV 5CSW LYS A 551 UNP P15056 ILE 551 ENGINEERED MUTATION SEQADV 5CSW ARG A 562 UNP P15056 GLN 562 ENGINEERED MUTATION SEQADV 5CSW ASN A 588 UNP P15056 LEU 588 ENGINEERED MUTATION SEQADV 5CSW SER A 630 UNP P15056 LYS 630 ENGINEERED MUTATION SEQADV 5CSW GLU A 667 UNP P15056 PHE 667 ENGINEERED MUTATION SEQADV 5CSW SER A 673 UNP P15056 TYR 673 ENGINEERED MUTATION SEQADV 5CSW ARG A 688 UNP P15056 ALA 688 ENGINEERED MUTATION SEQADV 5CSW SER A 706 UNP P15056 LEU 706 ENGINEERED MUTATION SEQADV 5CSW ARG A 709 UNP P15056 GLN 709 ENGINEERED MUTATION SEQADV 5CSW GLU A 713 UNP P15056 SER 713 ENGINEERED MUTATION SEQADV 5CSW GLU A 716 UNP P15056 LEU 716 ENGINEERED MUTATION SEQADV 5CSW GLU A 720 UNP P15056 SER 720 ENGINEERED MUTATION SEQADV 5CSW SER A 722 UNP P15056 EXPRESSION TAG SEQADV 5CSW GLY A 723 UNP P15056 EXPRESSION TAG SEQADV 5CSW PRO B 443 UNP P15056 ARG 443 ENGINEERED MUTATION SEQADV 5CSW ALA B 543 UNP P15056 ILE 543 ENGINEERED MUTATION SEQADV 5CSW SER B 544 UNP P15056 ILE 544 ENGINEERED MUTATION SEQADV 5CSW LYS B 551 UNP P15056 ILE 551 ENGINEERED MUTATION SEQADV 5CSW ARG B 562 UNP P15056 GLN 562 ENGINEERED MUTATION SEQADV 5CSW ASN B 588 UNP P15056 LEU 588 ENGINEERED MUTATION SEQADV 5CSW SER B 630 UNP P15056 LYS 630 ENGINEERED MUTATION SEQADV 5CSW GLU B 667 UNP P15056 PHE 667 ENGINEERED MUTATION SEQADV 5CSW SER B 673 UNP P15056 TYR 673 ENGINEERED MUTATION SEQADV 5CSW ARG B 688 UNP P15056 ALA 688 ENGINEERED MUTATION SEQADV 5CSW SER B 706 UNP P15056 LEU 706 ENGINEERED MUTATION SEQADV 5CSW ARG B 709 UNP P15056 GLN 709 ENGINEERED MUTATION SEQADV 5CSW GLU B 713 UNP P15056 SER 713 ENGINEERED MUTATION SEQADV 5CSW GLU B 716 UNP P15056 LEU 716 ENGINEERED MUTATION SEQADV 5CSW GLU B 720 UNP P15056 SER 720 ENGINEERED MUTATION SEQADV 5CSW SER B 722 UNP P15056 EXPRESSION TAG SEQADV 5CSW GLY B 723 UNP P15056 EXPRESSION TAG SEQRES 1 A 282 GLY PRO ARG ASP SER SER ASP ASP TRP GLU ILE PRO ASP SEQRES 2 A 282 GLY GLN ILE THR VAL GLY GLN ARG ILE GLY SER GLY SER SEQRES 3 A 282 PHE GLY THR VAL TYR LYS GLY LYS TRP HIS GLY ASP VAL SEQRES 4 A 282 ALA VAL LYS MET LEU ASN VAL THR ALA PRO THR PRO GLN SEQRES 5 A 282 GLN LEU GLN ALA PHE LYS ASN GLU VAL GLY VAL LEU ARG SEQRES 6 A 282 LYS THR ARG HIS VAL ASN ILE LEU LEU PHE MET GLY TYR SEQRES 7 A 282 SER THR LYS PRO GLN LEU ALA ILE VAL THR GLN TRP CYS SEQRES 8 A 282 GLU GLY SER SER LEU TYR HIS HIS LEU HIS ALA SER GLU SEQRES 9 A 282 THR LYS PHE GLU MET LYS LYS LEU ILE ASP ILE ALA ARG SEQRES 10 A 282 GLN THR ALA ARG GLY MET ASP TYR LEU HIS ALA LYS SER SEQRES 11 A 282 ILE ILE HIS ARG ASP LEU LYS SER ASN ASN ILE PHE LEU SEQRES 12 A 282 HIS GLU ASP ASN THR VAL LYS ILE GLY ASP PHE GLY LEU SEQRES 13 A 282 ALA THR VAL LYS SER ARG TRP SER GLY SER HIS GLN PHE SEQRES 14 A 282 GLU GLN LEU SER GLY SER ILE LEU TRP MET ALA PRO GLU SEQRES 15 A 282 VAL ILE ARG MET GLN ASP SER ASN PRO TYR SER PHE GLN SEQRES 16 A 282 SER ASP VAL TYR ALA PHE GLY ILE VAL LEU TYR GLU LEU SEQRES 17 A 282 MET THR GLY GLN LEU PRO TYR SER ASN ILE ASN ASN ARG SEQRES 18 A 282 ASP GLN ILE ILE GLU MET VAL GLY ARG GLY SER LEU SER SEQRES 19 A 282 PRO ASP LEU SER LYS VAL ARG SER ASN CYS PRO LYS ARG SEQRES 20 A 282 MET LYS ARG LEU MET ALA GLU CYS LEU LYS LYS LYS ARG SEQRES 21 A 282 ASP GLU ARG PRO SER PHE PRO ARG ILE LEU ALA GLU ILE SEQRES 22 A 282 GLU GLU LEU ALA ARG GLU LEU SER GLY SEQRES 1 B 282 GLY PRO ARG ASP SER SER ASP ASP TRP GLU ILE PRO ASP SEQRES 2 B 282 GLY GLN ILE THR VAL GLY GLN ARG ILE GLY SER GLY SER SEQRES 3 B 282 PHE GLY THR VAL TYR LYS GLY LYS TRP HIS GLY ASP VAL SEQRES 4 B 282 ALA VAL LYS MET LEU ASN VAL THR ALA PRO THR PRO GLN SEQRES 5 B 282 GLN LEU GLN ALA PHE LYS ASN GLU VAL GLY VAL LEU ARG SEQRES 6 B 282 LYS THR ARG HIS VAL ASN ILE LEU LEU PHE MET GLY TYR SEQRES 7 B 282 SER THR LYS PRO GLN LEU ALA ILE VAL THR GLN TRP CYS SEQRES 8 B 282 GLU GLY SER SER LEU TYR HIS HIS LEU HIS ALA SER GLU SEQRES 9 B 282 THR LYS PHE GLU MET LYS LYS LEU ILE ASP ILE ALA ARG SEQRES 10 B 282 GLN THR ALA ARG GLY MET ASP TYR LEU HIS ALA LYS SER SEQRES 11 B 282 ILE ILE HIS ARG ASP LEU LYS SER ASN ASN ILE PHE LEU SEQRES 12 B 282 HIS GLU ASP ASN THR VAL LYS ILE GLY ASP PHE GLY LEU SEQRES 13 B 282 ALA THR VAL LYS SER ARG TRP SER GLY SER HIS GLN PHE SEQRES 14 B 282 GLU GLN LEU SER GLY SER ILE LEU TRP MET ALA PRO GLU SEQRES 15 B 282 VAL ILE ARG MET GLN ASP SER ASN PRO TYR SER PHE GLN SEQRES 16 B 282 SER ASP VAL TYR ALA PHE GLY ILE VAL LEU TYR GLU LEU SEQRES 17 B 282 MET THR GLY GLN LEU PRO TYR SER ASN ILE ASN ASN ARG SEQRES 18 B 282 ASP GLN ILE ILE GLU MET VAL GLY ARG GLY SER LEU SER SEQRES 19 B 282 PRO ASP LEU SER LYS VAL ARG SER ASN CYS PRO LYS ARG SEQRES 20 B 282 MET LYS ARG LEU MET ALA GLU CYS LEU LYS LYS LYS ARG SEQRES 21 B 282 ASP GLU ARG PRO SER PHE PRO ARG ILE LEU ALA GLU ILE SEQRES 22 B 282 GLU GLU LEU ALA ARG GLU LEU SER GLY HET P06 A 801 35 HET P06 B 801 35 HET CL B 802 1 HETNAM P06 DABRAFENIB HETNAM CL CHLORIDE ION HETSYN P06 N-{3-[5-(2-AMINOPYRIMIDIN-4-YL)-2-TERT-BUTYL-1,3- HETSYN 2 P06 THIAZOL-4-YL]-2-FLUOROPHENYL}-2,6- HETSYN 3 P06 DIFLUOROBENZENESULFONAMIDE FORMUL 3 P06 2(C23 H20 F3 N5 O2 S2) FORMUL 5 CL CL 1- FORMUL 6 HOH *16(H2 O) HELIX 1 AA1 THR A 491 ARG A 506 1 16 HELIX 2 AA2 LEU A 537 ALA A 543 1 7 HELIX 3 AA3 GLU A 549 LYS A 570 1 22 HELIX 4 AA4 LYS A 578 ASN A 580 5 3 HELIX 5 AA5 SER A 616 MET A 620 5 5 HELIX 6 AA6 ALA A 621 MET A 627 1 7 HELIX 7 AA7 SER A 634 GLY A 652 1 19 HELIX 8 AA8 ASN A 661 GLY A 672 1 12 HELIX 9 AA9 ASP A 677 VAL A 681 5 5 HELIX 10 AB1 PRO A 686 LEU A 697 1 12 HELIX 11 AB2 LYS A 700 ARG A 704 5 5 HELIX 12 AB3 SER A 706 LEU A 721 1 16 HELIX 13 AB4 THR B 491 ARG B 506 1 16 HELIX 14 AB5 SER B 536 ALA B 543 1 8 HELIX 15 AB6 GLU B 549 LYS B 570 1 22 HELIX 16 AB7 GLU B 586 ASN B 588 5 3 HELIX 17 AB8 SER B 616 MET B 620 5 5 HELIX 18 AB9 ALA B 621 ARG B 626 1 6 HELIX 19 AC1 SER B 634 GLY B 652 1 19 HELIX 20 AC2 ASN B 661 ARG B 671 1 11 HELIX 21 AC3 ASP B 677 VAL B 681 5 5 HELIX 22 AC4 PRO B 686 LEU B 697 1 12 HELIX 23 AC5 LYS B 700 ARG B 704 5 5 HELIX 24 AC6 SER B 706 LEU B 721 1 16 SHEET 1 AA1 5 THR A 458 SER A 465 0 SHEET 2 AA1 5 THR A 470 LYS A 475 -1 O VAL A 471 N GLY A 464 SHEET 3 AA1 5 ASP A 479 MET A 484 -1 O VAL A 482 N TYR A 472 SHEET 4 AA1 5 ALA A 526 GLN A 530 -1 O ILE A 527 N LYS A 483 SHEET 5 AA1 5 PHE A 516 SER A 520 -1 N MET A 517 O VAL A 528 SHEET 1 AA2 3 GLY A 534 SER A 536 0 SHEET 2 AA2 3 ILE A 582 HIS A 585 -1 O LEU A 584 N SER A 535 SHEET 3 AA2 3 THR A 589 ILE A 592 -1 O LYS A 591 N PHE A 583 SHEET 1 AA3 5 THR B 458 SER B 465 0 SHEET 2 AA3 5 THR B 470 LYS B 475 -1 O VAL B 471 N GLY B 464 SHEET 3 AA3 5 ASP B 479 MET B 484 -1 O VAL B 482 N TYR B 472 SHEET 4 AA3 5 ALA B 526 GLN B 530 -1 O THR B 529 N ALA B 481 SHEET 5 AA3 5 PHE B 516 SER B 520 -1 N MET B 517 O VAL B 528 SHEET 1 AA4 2 ILE B 582 HIS B 585 0 SHEET 2 AA4 2 THR B 589 ILE B 592 -1 O LYS B 591 N PHE B 583 CISPEP 1 LYS A 522 PRO A 523 0 5.50 CISPEP 2 LYS B 522 PRO B 523 0 3.21 SITE 1 AC1 16 SER A 465 GLY A 466 VAL A 471 LYS A 483 SITE 2 AC1 16 LEU A 505 LEU A 514 ILE A 527 THR A 529 SITE 3 AC1 16 GLN A 530 TRP A 531 CYS A 532 PHE A 583 SITE 4 AC1 16 GLY A 593 ASP A 594 PHE A 595 HOH A 905 SITE 1 AC2 16 SER B 465 VAL B 471 LYS B 483 LEU B 505 SITE 2 AC2 16 LEU B 514 PHE B 516 ILE B 527 THR B 529 SITE 3 AC2 16 GLN B 530 TRP B 531 CYS B 532 PHE B 583 SITE 4 AC2 16 GLY B 593 ASP B 594 PHE B 595 HOH B 906 SITE 1 AC3 1 TRP B 450 CRYST1 114.359 48.095 101.168 90.00 95.32 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008744 0.000000 0.000814 0.00000 SCALE2 0.000000 0.020792 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009927 0.00000